Phone (303) 825-TUCC (8822)      Toll-Free (877) 825-8898

Urology News

Clinical advancements in the field of urology are featured in the news media every day. This section provides patients and physicians with the most up-to-date information on recent urologic advancements around the world.

* Please Note - TUCC does not necessarily advocate any of the treatment methods listed in the articles below. This news feed is provided as a resource for those interested in the latest urologic research occurring around the world.

  • August 19, 2015
    Common and rare variants associated with kidney stones and biochemical traits

    Kidney stone disease is a complex disorder with a strong genetic component. We conducted a genome-wide association study of 28.3 million sequence variants detected through whole-genome sequencing of 2,636 Icelanders that were imputed into 5,419 kidney stone cases, including 2,172 cases with a history of recurrent kidney stones, and 279,870 controls.

  • July 9, 2015
    Bring back prostate screening

    For years, research on prostate cancer has sought an approach to screening that is more individualized than a one-size-fits-all measurement of the level of prostate-specific antigen in a man’s blood. These efforts are now paying off.

  • June 25, 2015
    Smoking increases risk of prostate cancer recurrence after surgery

    Smoking is a risk factor for biochemical recurrence of prostate cancer (PCa) following radical prostatectomy (RP), new study findings suggest.

  • June 11, 2015
    Study: High-fat diet Western diet impacts lifespan of men diagnosed with prostate cancer

    If you're one of the nearly 3 million men currently living with a diagnosis of prostate cancer, listen up: A new study says what you eat makes a big difference as to how long you'll live with your cancer.

  • June 5, 2015
    Zinc in the Body May Contribute to Kidney Stones

    New research on kidney stone formation reveals that zinc levels may contribute to kidney stone formation, a common urinary condition that can cause excruciating pain. The research found that zinc may be the core by which stone formation starts.

  • May 26, 2015
    'Chilling Effect' seen after USPSTF recommends against routine PSA testing

    When the United States Preventive Services Task Force (USPSTF) recommended against routine PSA screening for early detection of prostate cancer in May 2012, it caused a sea change in practice patterns among primary care physicians.

    The impact of the recommendations had “a significant chilling effect,” said Sam Chang, MD, a professor of Urology at Vanderbilt University Medical Center, who moderated a panel discussion on the topic at the 2015 American Urological Association (AUA) Annual Meeting.

  • May 7, 2015
    Prostate cancer-obesity link stronger in blacks

    Obesity is more strongly associated with elevated prostate cancer (PCa) risk among African-American than non-Hispanic white men, according to a new study.

    The finding is based on a prospective analysis of data from 22,673 non-Hispanic white (NHW) men and 3,398 African-American (AA) men who participated in the Selenium and Vitamin E Cancer Prevention Trial (SELECT). Study subjects had a median follow-up of 5.6 years, during which 1,723 were diagnosed with PCa.

  • April 7, 2015
    Scientists reveal genetic root of prostate cancer

    An international team of scientists have revealed the genetic root of prostate cancers in individual men, demonstrating that tumors share common gene faults which could potentially offer new targets for treatment. Prostate cancer is the second most common cancer and second leading cause of cancer death in men.

    The research, published in Nature, is part of the International Cancer Genome Consortium - a global project committed to revealing genetic changes driving prostate cancer using the most up-to-date gene-sequencing technology available.

  • February 4, 2015
    Surveillance yields excellent long-term outcomes in stage I testicular cancer

    Active surveillance is effective and yields good outcomes in patients with clinical stage I testicular cancer (CSI-TC) who underwent orchiectomy, according to a pair of studies published in the December and January issues of the Journal of Clinical Oncology.

    “Most patients with CSI-TC are cured by orchiectomy alone,” wrote study authors led by Christian Kollmannsberger, MD, of the University of British Columbia in Vancouver. “With highly effective chemotherapy providing a safety net, ultimate cure rates approach 100% irrespective of the postorchiectomy strategy employed.” Thus, diminishing morbidities associated with treatment is a primary concern.

  • January 6, 2015
    ADT plus RT more effective in reducing prostate cancer mortality than ADT alone in geriatric men

    Among older men with high-risk prostate cancer, receiving androgen-deprivation therapy in combination with radiotherapy reduced cause-specific and all-cause mortality by as much as 50% when compared with those who received androgen-deprivation therapy alone, results from a large-scale data review showed.

    In fact, men over the age of 65 with locally advanced prostate cancer risk significantly higher mortality rates if they are treated with androgen-deprivation therapy (ADT) without accompanying radiotherapy (RT), according to the authors of a study published online Jan. 5 in the Journal of Clinical Oncology.

Request an Appointment

TUCC is contracted with all major insurance companies. We look forward to providing you with clinically advanced, compassionate urologic care.

read more »